Accelerating COVID-19 Research Using Molecular Dynamics Simulation
- PMID: 34319118
- DOI: 10.1021/acs.jpcb.1c04556
Accelerating COVID-19 Research Using Molecular Dynamics Simulation
Abstract
The COVID-19 pandemic has emerged as a global medico-socio-economic disaster. Given the lack of effective therapeutics against SARS-CoV-2, scientists are racing to disseminate suggestions for rapidly deployable therapeutic options, including drug repurposing and repositioning strategies. Molecular dynamics (MD) simulations have provided the opportunity to make rational scientific breakthroughs in a time of crisis. Advancements in these technologies in recent years have become an indispensable tool for scientists studying protein structure, function, dynamics, interactions, and drug discovery. Integrating the structural data obtained from high-resolution methods with MD simulations has helped in comprehending the process of infection and pathogenesis, as well as the SARS-CoV-2 maturation in host cells, in a short duration of time. It has also guided us to identify and prioritize drug targets and new chemical entities, and to repurpose drugs. Here, we discuss how MD simulation has been explored by the scientific community to accelerate and guide translational research on SARS-CoV-2 in the past year. We have also considered future research directions for researchers, where MD simulations can help fill the existing gaps in COVID-19 research.
Similar articles
-
Possibility of HIV-1 protease inhibitors-clinical trial drugs as repurposed drugs for SARS-CoV-2 main protease: a molecular docking, molecular dynamics and binding free energy simulation study.J Biomol Struct Dyn. 2021 Sep;39(15):5368-5375. doi: 10.1080/07391102.2020.1786459. Epub 2020 Jul 6. J Biomol Struct Dyn. 2021. PMID: 32627689 Free PMC article.
-
Integrated docking and enhanced sampling-based selection of repurposing drugs for SARS-CoV-2 by targeting host dependent factors.J Biomol Struct Dyn. 2022;40(20):9897-9908. doi: 10.1080/07391102.2021.1937319. Epub 2021 Jun 22. J Biomol Struct Dyn. 2022. PMID: 34155961 Free PMC article.
-
Lessons Learnt from COVID-19: Computational Strategies for Facing Present and Future Pandemics.Int J Mol Sci. 2023 Feb 23;24(5):4401. doi: 10.3390/ijms24054401. Int J Mol Sci. 2023. PMID: 36901832 Free PMC article. Review.
-
Molecular Binding Mechanism and Pharmacology Comparative Analysis of Noscapine for Repurposing against SARS-CoV-2 Protease.J Proteome Res. 2020 Nov 6;19(11):4678-4689. doi: 10.1021/acs.jproteome.0c00367. Epub 2020 Sep 4. J Proteome Res. 2020. PMID: 32786685
-
Proteomics advances towards developing SARS-CoV-2 therapeutics using in silico drug repurposing approaches.Drug Discov Today Technol. 2021 Dec;39:1-12. doi: 10.1016/j.ddtec.2021.06.004. Epub 2021 Jun 24. Drug Discov Today Technol. 2021. PMID: 34906319 Free PMC article. Review.
Cited by
-
Intelligent resolution: Integrating Cryo-EM with AI-driven multi-resolution simulations to observe the severe acute respiratory syndrome coronavirus-2 replication-transcription machinery in action.Int J High Perform Comput Appl. 2022 Nov;36(5-6):603-623. doi: 10.1177/10943420221113513. Epub 2022 Aug 5. Int J High Perform Comput Appl. 2022. PMID: 38464362 Free PMC article.
-
Delineating the Structure-Dynamics-Binding Differences among BA.1, BA.4/5, and BF.7 SARS-CoV-2 Variants through Atomistic Simulations: Correlation with Structural and Epidemiological Features.ACS Omega. 2023 Oct 3;8(41):37852-37863. doi: 10.1021/acsomega.3c02904. eCollection 2023 Oct 17. ACS Omega. 2023. PMID: 37867647 Free PMC article.
-
In silico screening, ADMET analysis and MD simulations of phytochemicals of Onosma bracteata Wall. as SARS CoV-2 inhibitors.3 Biotech. 2023 Jul;13(7):221. doi: 10.1007/s13205-023-03635-7. Epub 2023 May 31. 3 Biotech. 2023. PMID: 37265541 Free PMC article.
-
Bionics design of affinity peptide inhibitors for SARS-CoV-2 RBD to block SARS-CoV-2 RBD-ACE2 interactions.Heliyon. 2023 Jan;9(1):e12890. doi: 10.1016/j.heliyon.2023.e12890. Epub 2023 Jan 13. Heliyon. 2023. PMID: 36686609 Free PMC article.
-
Lessons Learned from Responsive Molecular Dynamics Studies of the COVID-19 Virus.Proc UrgentHPC 2021 (2021). 2021 Nov;2021:1-10. doi: 10.1109/urgenthpc54802.2021.00006. Epub 2021 Dec 20. Proc UrgentHPC 2021 (2021). 2021. PMID: 36573923 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous